INDEPENDENT NEWS

Comvita sees annual earnings lift of up to 32%

Published: Wed 24 Sep 2014 10:51 AM
Comvita sees annual earnings lift of up to 32%, bemoans bigger half-year split
By Paul McBeth
Sept. 24 (BusinessDesk) - Comvita, which produces health products derived from manuka honey, sees annual earnings growth of up to 32 percent, while bemoaning a growing imbalance between the first and second halves of the year.
The Te Puke-based company expects net profit of between $9 million and $10 million in the year ending March 31, 2015, up from $7.6 million a year earlier, on revenue of between $140 million and $145 million, up from $115 million, it said in a statement. That will largely come through in the second half of the year, due to uneven sales between the northern and southern hemispheres, and after the honey harvest is collected between January and May next year, which will generate revenue from the beekeeping operations.
The split in half-year performance means Comvita anticipates to report a net loss of $4 million in the six months ending Sept. 30 on sales of $56 million, compared to a net loss of $800,000 on revenue of $43 million a year earlier. The loss stems from the accounting treatment of the beekeeping operations, a revaluation of its warrants in Nasdaq-listed Derma Sciences, and acquisitions costs from New Zealand Honey.
"We thought it was important to communicate how the changes to the business impact in the half year and full year reporting," chief executive Brett Hewlett said. "The performance of the business is trending in line with internal forecasts and we expect to be able to report an increase in net earnings of greater than 20 percent for the full year."
In July Comvita acquired Timaru-based New Zealand Honey Producers Cooperative for $12.3 million, the latest in the firm's pipeline of apiary acquisitions to shore up its own supply of raw honey.
The shares were unchanged at $3.65, and have edged up 0.6 percent this year, lagging the 7.1 percent gain on the NZX All Index over the same period. The stock is rated a 'hold' according to the one analyst recommendation compiled by Reuters, with a price target of $3.64.
(BusinessDesk)
BusinessDesk
Independent, Trustworthy New Zealand Business News
The Wellington-based BusinessDesk team provides a daily news feed for a serious business audience.
Contact BusinessDesk
Email:

Next in Business, Science, and Tech

What Lies Beneath Is The Housing Market Turning?
By: Quotable Value New Zealand
KiwiRail strike notices withdrawn following new offer
By: Rail And Maritime Transport Union
Stress Tests Show Strengthening Bank Resilience
By: Reserve Bank
Deputy Governor Reflects On Time At RBNZ
By: Reserve Bank
Data Reveals ICT Expenditure Key To Small Business Sales Growth
By: Xero
Fonterra Lifts Forecast Farmgate Milk Price Range And Revises Earnings Guidance At First Quarter Update
By: Fonterra
Canterbury Museum: New Research - Bald Haast's Eagle Feasted On Moa Guts
By: Canterbury Museum
View as: DESKTOP | MOBILE © Scoop Media